86,086 patient-years during which a total of 1,930 (75.7%) of the diabetic patients and 5,744 (58.5%) of the nondiabetic patients died (p ! 0.001). Median survival was 60 months (95% CI: 57-64) in diabetic patients and 117 months (113)(114)(115)(116)(117)(118)(119)(120) in the nondiabetic patients. Survival improved significantly in both groups (p ! 0.001). A Cox regression, adjusting for possible confounders (age, sex, antihypertensive medication, antithrombotics or other thrombolytic agents, history of myocardial infarction, type of stroke, diabetes, cohort and the diabetes-by-sex, diabetes-by-age and diabetes-by-cohort interactions), showed a hazard ratio of 1.67 (1.58-1.76) comparing survival in diabetic versus nondiabetic patients. The reduced survival in diabetic stroke patients was more pronounced in women (p = 0.02) and younger patients (p ! 0.001). There was a tendency that the difference in survival decreased between the earlier cohorts and the 2000-2005 cohort, but the test for interaction did not reach statistical significance (p = 0.08). Conclusion: Long-term survival after a first stroke has improved in both diabetic and nondiabetic patients. Survival is markedly lower in diabetics, especially in women and younger patients, and the disparity persisted over 24 years. Decreasing the disparity in stroke survival is a challenge for stroke and diabetes care. New treatment methods in combination with intense secondary prevention in diabetic patients, especially in younger women, are needed. 
Introduction
Patients with diabetes have a two-to threefold increased risk of stroke, and diabetes is present in 15-27% of all incident strokes in the USA [1, 2] . Although ischemic and recurrent strokes are more common in persons with diabetes than in those without diabetes, transient ischemic attacks and hemorrhagic stroke are less common. Around 40% of ischemic strokes are due to diabetes [3] . In Sweden, diabetes was present among 12% of the patients dying due to stroke during the period 1997-2010, and there has been no decrease or increase over time in that percentage [4] .
Most studies agree that fatality up to 1 year after a stroke is increased in diabetic patients [5] [6] [7] [8] and that diabetes increases the risk of cardiovascular events and death within 2 years after ischemic stroke [9] . Meanwhile, data on long-term survival is scant. Two recent Danish studies found that diabetes is associated with much lower survival at 10-12 years' follow-up [5, 10] . In a veteran study, restricted to men suffering an ischemic stroke during 1990-1997, long-term mortality was lower in patients with diabetes, although much improved compared to earlier studies [11] .
We wished to assess the impact of intensified primary and secondary prevention, including surgery for carotid stenosis and dedicated stroke units, on mortality among diabetic patients after a first stroke. Towards this goal, survival data over periods much longer than 1 year are needed to describe the secular trends over a period that includes the introduction of evidence-based cardiovascular diabetology [1] . In addition, data should include patients not treated in hospital or deceased before reaching the hospital.
Using population-based data, our objectives were to compare long-term survival after a first stroke between diabetic and nondiabetic patients, to assess if possible differences in survival have changed over time , and to determine if differences vary with respect to sex and age.
Methods
This study was based on the Northern Sweden MONICA Stroke Registry. The registry is population-based, and details of the event-registration procedure have been described previously [12] . The registry includes all acute stroke events in the age range 25-74 years in the two northernmost counties of Sweden, Norrbotten and Västerbotten, and the average total population in the target group aged 25-74 years was 313,800 during 1985-2005.
Suspected acute stroke events were identified through reports from hospitals and general practitioners, hospital discharge registers and death certificates. Suspected acute strokes were validated by a research nurse according to the WHO criteria as 'rapidly developing clinical signs of focal (or global) disturbance of cerebral function lasting more than 24 hours, with no apparent cause other than vascular origin' throughout the time period [13, 14] .
This study included intracerebral hemorrhages (ICH), ischemic strokes, and unspecified strokes (ICD-10: I61, I63 and I64) occurring between January 1, 1985 and December 31, 2005. Patients were excluded from the study if they had experienced a previous stroke event (according to the register or medical records). The diagnosis of diabetes was based on medical records or diabetes diagnosed during the acute stroke event.
The endpoint studied was death from any cause and stroke patients were followed up using the Swedish Cause of Death Registry (National Board of Health and Welfare) as of August 30, 2008. Patients not identified in the register were assumed to be alive at that date.
The patients were separated into four cohorts according to year of stroke: 1985-1989, 1990-1994, 1995-1999, and 2000-2005 .
The Northern Sweden MONICA study was approved by the regional ethical review board in Umeå. Patients or relatives to nonsurvivors gave written consent.
Statistical Analyses
Differences in baseline characteristics between diabetic and nondiabetic stroke patients were tested using 2 test for categorical variables and t-test for continuous variables.
The median survival time from stroke onset was presented for subgroups of patients. The log rank test was used for univariate comparisons of time to event between patient groups. Multiple Cox proportional hazard regression was used to analyze time to event, adjusting for potential confounders. The model included the independent variables age, sex, antihypertensive medication at onset, antithrombotics at onset (anticoagulants, acetylsalicylates, platelet antiaggregants, other thrombolytic agents), history of myocardial infarction, type of stroke (ICH/other), diabetes (yes/no), cohort (1985-1989, 1990-1994, 1995-1999, and 2000-2005) and the diabetes-by-sex, diabetes-by-age and diabetes-bycohort interactions. The smoking parameter contained a large amount of missing values (53%) and was therefore excluded from the multiple regression. Patients who were still alive at the end of the study, August 30, 2008, were censored at that time point. Kaplan-Meier survival curves were examined to identify deviations from the proportional hazard's assumption. Outcome was presented by hazard ratios (HR) with 95% confidence intervals (95% CI). IBM SPSS Statistics 19 was used for statistical analysis.
Results
Between 1985 and 2005, 12,477 18-to 74-year-old stroke patients with a first stroke were registered. Personal identification numbers were missing for 7 patients, and therefore those 7 were lost to follow-up. Eleven pa-tients had negative survival times, which suggest clerical errors, and those 11 were excluded from the analysis. Of the remaining patients, 84 lacked information on diabetes. Hence, complete data regarding diabetes and followup were available for 12,375 patients ( table 1 ) .
Of the stroke patients, 2,549 (20.6%) had diabetes of which 101 (4.0%) had type 1 diabetes, 2,092 (82.1%) type 2 diabetes, 253 (9.9%) had unspecified diabetes, and 103 (0.8)% were diagnosed with diabetes during the event.
The proportion of men in diabetic (61.6%) and nondiabetic groups (61.0%) were similar.
Patients with diabetes were on average 2 years older (66.2 vs. 64.2, p ! 0.001), were less likely to smoke (32.2 vs. 37.7%, p = 0.001), and had more often antihypertensive treatment (71.3 vs. 44.8%, p ! 0.001) or antithrombotics (32.2 vs. 20.1%, p ! 0.001) at stroke onset. Patients with diabetes had atrial fibrillation (17.1 vs. 13.2%, p ! 0.001), history of myocardial infarction (20.7 vs. 12.3%, p ! 0.001), and previous transient ischemic attack (5.7 vs. 4 .2%, p = 0.036) more often than nondiabetic patients. Diabetic patients were more often fully conscious at hospital arrival (90.5 vs. 87.6%, p = 0.006), and less likely to have ICH (7.4 vs. 15.4%, p ! 0.001). The prevalence of diabetes, the proportion of men, and the mean age remained stable during the four time periods.
Patients were followed for a median time of 6.1 years (74 months) and a maximum of 23.7 years (284 months). The total follow-up time was 86,086 patient-years during which a total 1,930 (75.7%) of the diabetic patients and 5,744 (58.5%) of the nondiabetic patients died (p ! 0.001). The median survival was 5.0 years (95% CI: 4.7-5.4) in the diabetic and 9.7 years (95% CI: 9.4-10.0) in the nondiabetic stroke patients. The mortality rates in diabetic (nondiabetic) patients were 15% (12%) at 28 days, 25% (18%) at 1 year, 38% (25%) at 3 years, 50% (32%) at 5 years, and 73% (51%) at 10 years after stroke. For each of the successive cohorts, mortality rates decreased both for diabetic and nondiabetic patients ( fig. 1 ). The reduced survival in diabetic, as compared to nondiabetic, patients was evident in both men and women in all time periods (p ! 0.001 using log rank tests for each cohort, table 2 ).
A multiple Cox regression confirmed the disparity in survival between diabetics and nondiabetics (HR = 1.67, 95% CI: 1.58-1.76). Other factors associated with increased mortality were higher age, male sex, antihypertensive medication at onset, atrial fibrillation, history of myocardial infarction, and hemorrhagic stroke ( table 3 ) . Including interactions in the regression showed that the relative difference between diabetic and nondiabetic patients was smaller in men (diabetes-by-sex interaction HR = 0.88, p = 0.025) and decreased with higher age (diabetes-by-age interaction HR = 0.98, p ! 0.001; table 3 , fig. 2 ). There was also a tendency toward decreased difference during 2000-2005 as compared to earlier years ( fig. 1 ), but the diabetes-by-cohort interaction effect did not reach statistical significance (p = 0.08). 
Discussion
Long-term survival after a first stroke has improved, and the improvement has been at least as good in diabetic patients as in nondiabetic patients. However, the survival of a diabetic patient suffering a stroke after 2000 was similar to the survival of a patient without diabetes who had his stroke in the late eighties. The markedly lower survival in stroke patients with diabetes, as compared to patients without diabetes, persisted between 1985 and 2005. The reduced survival after stroke in patients with diabetes was even more pronounced in women and younger patients. This study included stroke patients during a period of 21 years, and followed them for up to 23 years. Both stroke patients treated in hospital and patients who died outside of hospital were captured. A previous validation of the MONICA Stroke Registry using the National Patient Register (National Board of Health and Welfare) showed that MONICA has almost complete coverage in the selected age interval (unpublished data). During the extensive time period of this study, diagnostic methods have developed in clinical practice. The increased use of MRI and CT enables detection of strokes with very minor neurological symptoms, which may partly explain improved survival in both groups. A major strength of this study is the uniform methods and strict diagnosis criteria for stroke case ascertainment throughout the study period. This minimizes the effect of changes in clinical stroke diagnosis. The prevalence of diabetes has also remained at a stable level in the study population [15] . This study was limited to patients under 75 years with a first stroke, which excluded approximately half of all stroke patients. We observed a smaller difference in survival between diabetic and nondiabetic patients in the age group 65-74 years as compared to younger patients, and it is possible that other factors than diabetes influence survival more in the elderly. However, one should be cautious to extrapolate the findings of our study to more advanced age groups.
Stroke severity is an established predictor of outcome after stroke [5, 16] and we used level of consciousness as a proxy. The impact of stroke severity has been shown to be weaker for long-term survival [5] , and during the latter part of this study, where level of consciousness was registered, diabetic patients were slightly less often unconscious at presentation. Hence stroke severity was unlikely to explain the observed difference in survival between patients with and without diabetes.
Improved long-term survival after stroke has been observed in previous Swedish studies [17] [18] [19] . The present observed difference in survival between diabetic a nondiabetic stroke patients (HR = 1.66) was consistent with the difference reported from a Danish cohort study (HR = 1.74) [10] . The similar improvement, but persisting difference in long-term survival between diabetic and nondiabetic stroke patients, is in agreement with the development in 1-year case-fatality observed in Finnish ischemic stroke patients with and without type 2 diabetes [8] . A large cohort study from the UK using the General Practice Research Database showed that the increased relative risk of stroke in patients with type 2 diabetes compared to patients without diabetes was highest in women and decreased with age [20] . In the Finnish study, the highest excess 28-day stroke case fatality caused by diabetes was in younger women. We observed a similar pattern when it came to long-term survival after stroke, where the relative risk for patients with diabetes was more elevated in women and in younger patients. Hence, in addition to a higher risk of stroke, younger women with diabetes seem to have a worse prognosis after stroke. Interestingly, a recent study showed almost identical trends and disparities in long-term survival after a first myocardial infarction among diabetic subjects within the Northern Sweden MONICA study [21] , implying common pathways not reversed by traditional risk factor treatment.
A recent population-based study showed increased use of lipid-lowering agents and antihypertensive drugs, and substantial improvements in cardiovascular risk factors (blood pressure, smoking, cholesterol levels and education) in northern Sweden between 1986 and 2009 [15] . Lifestyle changes, improved secondary prevention, more patients being treated in stroke units and the use of stroke thrombolysis have probably all contributed to the increased survival after stroke in the general population. The recently noted improved blood pressure control among Swedish patients with type 2 diabetes will reduce both risks of stroke and of mortality after a stroke [22] . While no increase in stroke patients with diabetes was observed in our study, an increasing proportion of stroke patients with diabetes have been observed in the United States [23] .
Another study from the United States found quality of care to be comparable in patients with and without diabetes in most aspects with the exception that diabetic patients are less likely to receive stroke thrombolysis [24] , a difference that has also been seen in the Swedish stroke register [25] . Despite a probable treatment difference in thrombolysis, the difference in survival between diabetic and nondiabetic patients did not increase during the last period, during which thrombolysis for acute ischemic stroke was introduced in Sweden. The SPARCL study showed no difference in the effect of statin treatment to prevent recurrent stroke in patients with or without type 2 diabetes, but patients with diabetes still had an increased risk of recurrent stroke or cardiovascular disease [26] .
The worse survival in diabetic patients remained after adjustments for differences in risk factors. However, there may be other unmeasured confounders. Differences in socioeconomic status and other differences in case mix might partially explain the observed differences.
The similar favorable trend in survival in diabetic and non-diabetic patients suggests that acute stroke care and secondary prevention have been successful both in patients with and without diabetes. However, the treatment has not decreased the gap in long-term survival. The reason for the gap remains unclear, and decreasing the disparity in stroke survival is a challenge for stroke and diabetes care. New treatment methods in combination with intense secondary prevention in diabetic patients, especially in younger women, are needed.
